PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
2 hedge funds and large institutions have $3K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
0% more capital invested
Capital invested by funds: $3K → $3K ($0)
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
Top Sellers
PVCT Hedge Fund Activity: Q3 2017 in Review
2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q3 2017, worth a combined $3K — unchanged from a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PVCT and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
- 2 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q3 2017, down from 3 in Q2 2017.
- Funds reported $3K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q3 2017, unchanged quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q3 2017 and 2 closed out, a net change of -1 holder.
Based on aggregated 13F filings for Q3 2017.